United Therapeutics Corporation Reports First Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/9/2026
- S&P 500 ends down after Trump says Iran deal is 'over'
- Oil settles at multi-week high as US-Iran truce buckles under fresh hostilities
- Nvidia is up just 3% YTD while SOX surges 82% — what’s holding it back?
- BofA says S&P 500 technicals point to corrective Q3
- Alibaba rallies 12% after report of narrowing losses sparks pre-earnings optimism
- Morgan Stanley Reiterates Overweight Rating on Rocket Lab USA (RKLB), Bull Case Raised to $293
- GameStop stockholders approve share count increase to 2.5 billion
- Crude Inventory Rose 3 Million Barrels Last Week - EIA
- AI bubble fears mount as Zuckerberg admits agent delays and Burry shorts sector
- S&P 500 ends down after Trump says Iran deal is 'over'
United Therapeutics (UTHR) Tops Q1 EPS by 89c, Revenues Beat
April 29, 2020 6:16 AM EDTUnited Therapeutics (NASDAQ: UTHR) reported Q1 EPS of $3.61, $0.89 better than the analyst estimate of $2.72. Revenue for the quarter came in at $356.3 million versus the consensus estimate of $344.33 million.
"I'm proud of the efforts of the entire United Therapeutics team to ensure continued access to our life-sustaining... More
